Abstract: In a water treatment system and a water treatment process, a scale inhibitor is supplied to water to be treated containing Ca ions, SO4 ions, carbonate ions, and silica, and the water to be treated is adjusted to a pH at which silica is soluble. The pH-adjusted water containing the calcium scale inhibitor is separated in a first demineralizing section into concentrated and treated water. In a first crystallizing section, seed crystals of gypsum are supplied to the first concentrated water, whereby gypsum is crystallized and removed from the first concentrated water. Silica in the water to be treated is removed from the first concentrated water on the downstream side of the first crystallizing section. Calcium carbonate in the water to be treated is removed from the first concentrated water on the upstream side of the first demineralizing section or the downstream side of the first crystallizing section.

Abstract: Provided are a water treatment system and a water treatment process, which are capable of reproducing water containing salts with high water recovery. In the water treatment system (200) and the water treatment process of the present invention, after a calcium scale inhibitor and a silica scale inhibitor are supplied to water to be treated containing Ca ions, SO4 ions, carbonate ions, and silica, and the water to be treated is separated in a second demineralizing section (210) into second concentrated water in which the Ca ions, the SO4 ions, the carbonate ions, and the silica are concentrated and treated water. In a second crystallizing section (220), seed crystals of gypsum are supplied to the second concentrated water, whereby gypsum is crystallized and removed from the second concentrated water.

Abstract: Provided are a water treatment system and a water treatment process, which are capable of reproducing water containing salts with high water recovery. In the water treatment system (400) and the water treatment process of the present invention, after a calcium scale inhibitor and a silica scale inhibitor are supplied to water to be treated containing Ca ions, SO4 ions, carbonate ions, and silica, and the water to be treated is separated in a second demineralizing section (210) into second concentrated water in which the Ca ions, the SO4 ions, the carbonate ions, and the silica are concentrated and treated water. In a second crystallizing section (220), seed crystals of gypsum are supplied to the second concentrated water, whereby gypsum is crystallized and removed from the second concentrated water.

Abstract: In a water treatment system (1) and a water treatment process, a scale inhibitor is supplied to water to be treated containing Ca ions, SO4 ions, carbonate ions, and silica, and the water to be treated is adjusted to a pH at which silica is soluble. The pH-adjusted water to be treated containing the calcium scale inhibitor is separated in a demineralizing section (10) into concentrated water and treated water. In a crystallizing section (20), seed crystals of gypsum are supplied to the concentrated water, whereby gypsum is crystallized and removed. Silica in the water to be treated is removed from the concentrated water on the downstream side of the crystallizing section (20). Calcium carbonate in the water to be treated is removed from the concentrated water on the upstream side of the demineralizing section (10) or the downstream side of the crystallizing section (20).

Abstract: Provided are a water treatment system and a water treatment process, which are capable of reproducing water containing salts with high water recovery. A water treatment system 100 comprises a second demineralizing section 210a, 210b that separates water to be treated containing Ca ions, SO4 ions and carbonate ions into concentrated water in which the Ca ions and the SO4 ions are concentrated and treated water; a crystallizing section which is positioned on a downstream side of the second demineralizing section 210a, 210b and which includes a second crystallizing tank 221a, 221b that crystallizes gypsum from the concentrated water and a seed crystal supplying section that supplies seed crystals of gypsum to the second crystallizing tank 221a, 221b; and a separating section that is positioned on a downstream side of the crystallizing section and separates the gypsum from the concentrated water.

Abstract: A water treatment system includes a first demineralizing section that separates water to be treated including Ca ions, SO4 ions, and carbonate ions into concentrated water and treated water; a crystallizing section including a first crystallizing tank 21 that crystallizes gypsum from the concentrated water and a first seed crystal supplying section 22 that supplies seed crystals of gypsum to the first crystallizing tank 21; a first pH measuring section 543 that measures the pH of the first concentrated water in the first crystallizing tank 21; and a first controlling section that reduces the amount of the seed crystals of the gypsum to be supplied when the measured pH falls within a pH range in which a scale inhibition function of the calcium scale inhibitor is reduced, and increases the amount of the seed crystals of the gypsum to be supplied when the measured pH is beyond the pH range.

Abstract: The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.

Abstract: A saccharide-solution producing apparatus 11A according to the present invention is a saccharide-solution producing apparatus for producing a saccharide solution 22 derived from a carbohydrate-based material 21, and includes a saccharide-solution controlling unit 15A that controls the saccharide solution derived from the carbohydrate-based material 21, a cellulosic biomass saccharifying unit 16 that saccharifies hydrothermally treated biomass obtained by hydrothermally decomposing a cellulosic biomass material 35 that contains a lignin component and a hemicellulose component, and produces a diluted saccharide solution 37, and a diluted-saccharide-solution supply pipe L11 that mixes the diluted saccharide solution 37 produced by the cellulosic biomass saccharifying unit 16 into the saccharide-solution controlling unit 15A. With this configuration, it is possible to improve production efficiency of the saccharide solution 22 and to realize cost reduction.

Abstract: There is provided a projection apparatus including a plurality of light-emitting devices for respectively emitting lights of a plurality of colors, a projecting unit for forming an optical image of a plurality of color components for each frame and sequentially projecting the optical image, and a power control unit for adjusting power to be supplied to the plurality of light-emitting devices to correct a decrease in luminance due to heat generation of the plurality of light-emitting devices.

Abstract: When it is detected that electronic paper is mounted on an electronic pad, the electronic paper, on which content is displayed, is transmitted to an electronic paper management server on a cloud system and registered to correspond to a pad ID of the electronic pad, a paper ID of the electronic paper and content display data that is being displayed. Then, when it is detected that electronic paper is newly mounted, if the combination of the pad ID of the electronic pad and the paper ID of the electronic paper is registered in the electronic paper management server, the content display data that is registered to correspond to the combination of the electronic pad ID and the electronic paper ID is redisplayed on the electronic paper received from the management server.

Abstract: The present invention provides a compound useful for the prophylaxis or treatment of eicosanoid-associated diseases such as atherosclerosis, atherothrombosis, diabetes, obesity, asthma, fever, pain, cancer, rheumatism, osteoarthritis, atopic dermatitis and the like, and having superior pharmacological action, physicochemical properties and the like. The present invention relates to a compound represented by the following formula: wherein each symbol is as defined in the specification, or a salt thereof.

Abstract: An information device makes a payment with a payment terminal through a contactless communication, using amount data of an electronic purse function of a mobile device. The mobile device with the electronic purse function permits the information device to be used for performing payment processing with the payment terminal, using amount data of the electronic purse function of the mobile device. A wearable information device includes an image taking unit configured to take an image of an object in the direction of line of vision of a user, and notifies the information device of the presence or absence of the information device in a taken image. The information device makes a payment with the payment terminal through a contactless communication based on the notification from the wearable information device of the presence or absence of the information device.

Abstract: A biomass hydrothermal decomposition apparatus includes, a biomass feeder (31) that feeds biomass material (11) under normal pressure to under increased pressure, a hydrothermal decomposition device (42A) that allows the fed biomass material (11) to be gradually moved inside a device main body (42A) from either end thereof in a consolidated condition, and also allows hot compressed water (15) to be fed from an other end of a feed section for the biomass material into the main body (42A), so as to cause the biomass material (11) and the hot compressed water (15) to countercurrently contact with each other and undergo hydrothermal decomposition, and that elutes a lignin component and a hemicellulose component into the hot compressed water, so as to separate the lignin component and the hemicellulose component from the biomass material (11); and a biomass discharger (51) that discharges, from the side where the hot compressed water is fed into the device main body, a biomass solid residue (17) under increased pr

Abstract: A water treatment method and a water treatment system that are capable of treating water containing salts to allow recovery of treated water at a high ion removal rate and a high water recovery rate, and allow recovery of high quality gypsum are provided. In the water treatment system, the water to be treated containing Ca2+ and SO42? is separated into concentrated water in which Ca2+ and SO42? are concentrated and treated water containing CO2 in a first demineralizer so that the treated water is recovered. The concentrated water in the first demineralizer is adjusted to a pH at which calcium carbonate can be dissolved and the scale inhibition function of a scale inhibitor is reduced, and then is delivered to a crystallizing tank. In the crystallizing tank, gypsum is crystallized from the concentrated water in the first demineralizer. The gypsum is separated and recovered in a separating section.

Abstract: A cage 1,2,3,4-cyclopentanetetracarboxylic acid (1,3:2,4)-dianhydride compound represented by formula [1], and a polyimide obtained by condensing the compound with a diamine. With the compound, it is possible to provide a polyimide which shows no absorption in the ultraviolet region and is highly transparent to light, has high insulating properties, has improved heat resistance and processability, and has excellent solubility in organic solvents. (In formula [1], R1 and R2 each independently represents a hydrogen atom, a halogen atom, or a C1-10 alkyl.

Abstract: A driving device includes a power source that converts input power to output power, first and second capacitors connected to an output of the power source, a load selector, and a capacitor selector. The load selector opens/closes circuits of first and second loads connected to the output of the power source to alternately close these circuits such that the second-load circuit is closed after the opening of the first-load circuit. The capacitor selector opens/closes circuits of the first and second capacitors to alternately close these circuits such that the first-capacitor circuit is closed in synchronization with the closing of the first-load circuit, and such that the second-capacitor circuit is closed in synchronization with the closing of the second-load circuit. The capacitor selector opens the first-capacitor circuit after the opening of the first-load circuit.

Abstract: Provided is an aromatic ring compound having a GPR40 agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a GPR40 agonist activity, and is useful as an agent for the prophylaxis or treatment of diabetes and the like.

Abstract: A biomass processing system includes: a hydrolysis processing unit that decomposes, under a high-temperature/high-pressure condition, biomass feedstock in a processing tank having a gas-liquid interface, and removes a lignin component and a hemicellulose component; a biomass solid content discharge unit that discharges a biomass solid content 20 which is a hot water insoluble element; a slurrying vessel that subjects the discharged biomass solid content to slurrying; and a hot water discharge liquid introducing line L2 that introduces, into the slurrying vessel 21, a hot water discharge liquid 16 including a biomass hot-water soluble element.

Abstract: The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.

Abstract: Provided is an aromatic ring compound having a GPR40 agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a GPR40 agonist activity, and is useful as an agent for the prophylaxis or treatment of diabetes and the like.